ArticleBlood advances2020
Identification of germline variants in adults with hemophagocytic lymphohistiocytosis.
Abstract read
In one paragraph
Article in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy.Haematologica · 2025Review
- X-linked lymphoproliferative disease type 1 (XLP1) due to a "de novo" missense SH2D1A Hemizygous Mutation Leading to Predominantly Antibody Deficiency.Research square · 2025Article
- Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS).Hematology/oncology clinics of North America · 2025Review
- [A case of hepatitis-associated aplastic anemia complicated by hemophagocytic lymphohistiocytosis and literature review].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025Review
- Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.Frontiers in oncology · 2025Review
- Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma.Blood advances · 2024Article
- Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors.Advances in experimental medicine and biology · 2024Review
- Genetics of Primary Hemophagocytic Lymphohistiocytosis.Advances in experimental medicine and biology · 2024Review
- Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis.Blood advances · 2023Article
- Article
- No association betweenHaematologica · 2021Article
- Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.Cell transplantationArticle
- Hemophagocytic lymphohistiocytosis in a child with human immunodeficiency virus infection - a case report.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Peter G MillerDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
Abhishek NiroulaDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
John J CeremsakHarvard-MIT Program in Health Sciences and Technology, and.
Christopher J GibsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
Martin S TaylorDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Sebastian BirndtKlinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
Florian PernerDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
Jon ArnasonDepartment of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Adam S SperlingDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
Mridul AgrawalDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
Alison M SchramDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Sarah NikiforowDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
German PihanDepartment of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Robert P HasserjianDepartment of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Jon C AsterDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Paul La RoséeKlinik für Innere Medizin II, Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany; and.
Elizabeth A MorganDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Nancy BerlinerDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Benjamin L EbertDepartment of Medical Oncology, Dana-Farber Cancer Institute, and.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MTYROSINE KINASE ONCOGENESIS IN MYELOID LEUKEMIAP01CA066996 · NCI · DANA-FARBER CANCER INSTITUTE · PI SCOTT A ARMSTRONG · 1996 to 2026
$52.5MDana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9MSYNTHESIS OF MATERIALS WITH PHYSIOLOGICAL PROPERTIESR01GM038627 · NIGMS · YALE UNIVERSITY · PI SCHREIBER, STUART L · 1987 to 2017
$10.5MTyrosine Kinases, Serine-Threonine Kinases,&Phosophatases in PathogenesisP01CA108631 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ESTEY, ELIHU · 2005 to 2009
$9.7MTraining Program in Molecular HematologyT32HL116324 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI NANCY BERLINER · 2013 to 2026
$7.4MTRAINING PROGRAM IN MOLECULAR HEMATOLOGYT32HL007623 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HANDIN, ROBERT I · 1985 to 2010
$7.0MFunctional Genomic Dissection of Refractory AnemiaR01HL082945 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI EBERT, BENJAMIN LEVINE · 2005 to 2022
$6.8MNCI NIH HHS K12 CA087723NCI NIH HHS P01 CA066996NCI NIH HHS P01 CA108631NCI NIH HHS P30 CA008748NHLBI NIH HHS R01 HL082945NHLBI NIH HHS T32 HL007623NHLBI NIH HHS T32 HL116324NIGMS NIH HHS R01 GM038627
Abstract
PubMed holds no abstract for this paper.
Indexed as
Lymphohistiocytosis, HemophagocyticAdultGerm CellsHumans
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.